Has Maura Cosetti, MD received payments from drug or device companies?

Yes. Drug and device makers reported $63,717 in general payments to Maura Cosetti, MD across 163 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Maura Cosetti, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Maura Cosetti, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Maura Cosetti, MD

Otolaryngology · Shreveport, LANPI 1841348422

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (44.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Cochlear Americas at 38.5% of the total. Reporting peaked in 2023 at $19,481 and has fallen 50.7% since, to $9,608 in 2025. Among otolaryngology clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$63,717in general payments, 2019–2025

Across 163 payments — averaging $390.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cochlear Americas$25K
Medtronic$14K
Johnson & Johnson$12K
Med-el Corporation$5K
Acclarent, Inc$4K
Medical Device Business Services, Inc.$2K
plus $2K from 5 others

$1,052,187in research payments, 2019–2025

Across 103 payments — averaging $10,215 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Med-el Corporation$524K
Cochlear Americas$436K
Otonomy, Inc.$57K
Advanced Bionics, LLC$35K

What the payments were for

Consulting fees$28,01144%
Speaking & faculty fees$12,56520%
Travel & lodging$14,02322%
Food & beverage$9,11914%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cochlear Americas	89	$24,509
Medtronic	9	$13,724
Johnson & Johnson	5	$11,808
Med-el Corporation	18	$5,224
Acclarent, Inc	15	$4,487
Medical Device Business Services, Inc.	10	$1,664
Grace Medical, Inc.	5	$972
Advanced Bionics, LLC	9	$689
Oticon Medical, LLC	1	$416
Stryker	1	$143
Iotamotion, Inc.	1	$83

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Cochlear Nucleus CI632 cochlear implant with Slim Modiolar electrode$21,150
Baha$20,847
OSIA OSI300 IMPLANT$19,254
Legend$13,625
TruDi Nav Cable$11,901
ACCLARENT Balloon Inflation Device$3,910
Cochlear$2,955
Mi1250 SYNCHRONY 2 FLEXsoft$2,726
BCI 602 Kit$2,726
ADHEAR Professional Kit$2,243
Baha BI300 implant 4 mm$1,896
Cochlear Osia OSI200 Implant$1,896
VIBRANT Soundbridge Middle Ear Implant and BONEBRIDGE System$899
MED-EL Maestro Cochlear Implant System$789
HIRES ULTRA CI HIFOCUS MS ELECTRODE$497
PONTO BONE ANCHORED HEARING SYSTEM$416
CORE$143
Nucleus$116

How this compares

$63,717 in reported general payments places this provider in the 95th percentile of 218 otolaryngology providers in Louisiana.

See all otolaryngology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$112,703

Medicare patients

243

Services billed

883

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Ofloxacin	33	$2,317
Fluticasone Propionate	29	$239
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	12	$87
Levofloxacin	11	$37

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Shreveport

Michael YimShreveport$77K
Cherie-Ann NathanShreveport$32K
Ameya AsarkarShreveport$8K
Vikas MehtaShreveport$8K
Roger BuiShreveport$5K
Jason CalligasShreveport$5K
Adam BlancherShreveport$4K
Rodrigo Martinez MonederoShreveport$3K
Karuna DewanShreveport$3K
Donald GonzalesNew Orleans$351K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →